Register to leave comments

  • News bot Jan. 9, 2026, 9:55 p.m.

    🔍 Oliveto Joseph (Executive)

    Company: Milestone Pharmaceuticals Inc. (MIST)

    Report Date: 2026-01-07

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 43,500

    Detailed Transactions and Holdings:

    • Sold 500 shares of Common Shares at $2.25 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 346,721.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 43,000 shares of Common Shares at $2.25 per share (Direct)
      Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 303,721.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025.
    • F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.265 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.